Business Context and Reporting Period
OrthoPediatrics Corp. (Nasdaq: KIDS) filed a Form 8-K on June 13, 2022, reporting the entry into a material definitive agreement. The company is incorporated in Delaware and operates in the orthopedic medical device sector.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, or specific liquidity ratios. The primary financial metric disclosed is the expansion of the company's revolving credit facility.
- Revolving Credit Facility Increase: The available amount under the revolving credit facility was increased from $25,000,000 to $50,000,000.
- Lender: Squadron Capital LLC.
- Instrument: Fourth Amendment to the Fourth Amended and Restated Loan and Security Agreement and a Second Amended and Restated Revolving Note.
Material Changes
The material change reported is the doubling of the company's available revolving credit capacity. This amendment was executed on June 13, 2022, modifying the original agreement dated December 31, 2017. No other material changes to financial performance or debt structure were disclosed in this specific report.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard incorporation of the loan agreement terms. The document notes that certain exhibits to the Amendment were omitted pursuant to Regulation S-K but will be furnished to the SEC upon request.
Investor Verification Checklist
- Verify the specific interest rates and covenants associated with the new $50,000,000 revolving credit facility by reviewing the full text of Exhibit 10.1 (Fourth Amendment) and Exhibit 10.2 (Amended Revolving Note).
- Confirm whether the company has drawn any funds against the increased facility since June 13, 2022, by checking subsequent 10-Q or 10-K filings.
- Review the company's most recent quarterly report to assess current liquidity needs relative to the expanded credit line.